Could a simple pill cut dangerous procedure complication in half?
NCT ID NCT05252754
Summary
This large Phase 3 trial aims to prevent pancreatitis, a painful and costly complication that can occur after a common gallbladder/bile duct procedure called ERCP. Researchers are testing whether adding an oral dose of the drug tacrolimus to the current standard preventive treatment (rectal indomethacin) is more effective. The study will enroll nearly 4,900 adults undergoing ERCP to see if the two-drug combination reduces the rate and severity of this complication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-ERCP ACUTE PANCREATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Apollo Multispecialty Hospitals,
NOT_YET_RECRUITINGKolkata, West Bengal, 700054, India
Contact Email: •••••@•••••
-
Asian Institute of Gastroenterology
RECRUITINGHyderabad, Andhra Pradesh, 500082, India
Contact Email: •••••@•••••
-
Johns Hopkins Hospital
RECRUITINGBaltimore, Maryland, 21287, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Post Graduate Institute of Medical Education and Research
NOT_YET_RECRUITINGChandigarh, 160012, India
Contact Email: •••••@•••••
-
Singapore General Hospital
NOT_YET_RECRUITINGSingapore, 169608, Singapore
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.